← Eichor
Condition: Epigenetic Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Epigenetic

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immun
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06694454Genetic and Epigenetic Basis of Chronic Wounds
Phase N/A · 1 location(s) · University of Pittsburgh · NCT03793062Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer.
Phase N/A · 1 location(s) · Origin Sciences · NCT05102110Remission Factors in Anorexia Nervosa
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04560517TORNADO-Omics Techniques and Neural Networks for the Development of Predictive Risk Models
Phase N/A · 1 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT06372054DNA Methylation and Vascular Function
NA · 1 location(s) · University of Illinois at Chicago · NCT03527420PRE-Pregnancy Weight Loss And the Reducing Effect on CHILDhood Overweight - Aarhus
NA · 1 location(s) · Ulla Kampmann Opstrup · NCT05798494"Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients"
Phase N/A · 1 location(s) · Ain Shams University · NCT06759714Colon Cancer Liquid Biopsy Investigation of Methylation-based Biomarkers Evaluation Using Delta-HLD (CLIMBED)
Phase N/A · 1 location(s) · Epiliquid Holding, Inc · NCT07168876Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT01005654Novel Epigenetic Mapping in Cell-Free DNA for the Detection of Lung Cancer
Phase N/A · 1 location(s) · JaxBio Ltd · NCT06963307Project SIRT6 Activator
NA · 2 location(s) · National University of Singapore · NCT07500649Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Phase 1 · 8 location(s) · Olema Pharmaceuticals, Inc. · NCT06784193Allopregnanolone and Dynamic GABA-A Receptor Plasticity in Selective Serotonin Reuptake Inhibitor Responsive Premenstrua
Phase 4 · 2 location(s) · Johns Hopkins University · NCT06704594Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Pr
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT05958719Diet-Induced Changes in GEnetic Material
Phase N/A · 1 location(s) · Pennington Biomedical Research Center · NCT06252922A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Sele
NA · 39 location(s) · Alimentiv Inc. · NCT07363044Colorectal Analysis for Signature Cancer Assessment Using Delta-HLD
Phase N/A · 1 location(s) · Epiliquid Holding, Inc · NCT07148297Self-harm Behaviour Among the Most At-risk Adolescents
Phase N/A · 2 location(s) · University of Ljubljana, Faculty of Medicine · NCT05765864Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing (GESTALT)
Phase N/A · 1 location(s) · National Institute on Aging (NIA) · NCT02339012ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal Cancer
Phase 2 · 8 location(s) · National Cancer Institute, Naples · NCT06714357A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer
EARLY_Phase 1 · 1 location(s) · Edwin Posadas, MD · NCT06888102To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigenetics, and
Phase N/A · 1 location(s) · Peking University People's Hospital · NCT07291921Identifying Predictors Of Response To Mepolizumab In CRSwNP
Phase 4 · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT05902325cfDNA 5mC/5hmC Biomarkers to Predict Chemotherapy Response in Metastatic Colorectal Cancer
Phase N/A · 1 location(s) · City of Hope Medical Center · NCT07224815Decoding Epigenetic Mechanisms Driving Immune Evasion in Liver Cancer With Omics Approaches
Phase N/A · 1 location(s) · Niguarda Hospital · NCT07432347ICU Biobank: Understanding Post-Intensive Care Syndrome (PICS)
Phase N/A · 1 location(s) · Medical University of Vienna · NCT06671795Pesticides and Infertility: Oxidative Stress Via Circulating Cell-free DNA and Gut/Genital Microbiome Signatures in Wome
NA · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT07471373Immune Resistance Interrogation Study
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT04243720A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Phase 1 · 2 location(s) · Monash University · NCT07428473
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.